arrow
H

Hassan Abdel-Aty

University of Calgary
H指数:29
被引数:7,128

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The STAMPEDE2 177Lutetium-PSMA-617 (177Lu-PSMA-617) trial: A phase III, randomised, open-label trial in patients with metastatic prostate cancer (mPC) starting androgen deprivation therapy (ADT)

STAMPEDE2 177Lutetium-PSMA-617 (177Lu-PSMA-617)试验:一项在开始雄激素剥夺疗法(ADT)的转移性前列腺癌(mPC)患者中进行的III期、随机、开放标签试验

2024-09-010
PRE
The STAMPEDE2 stereotactic ablative body radiotherapy (SABR) trial: A phase III, randomised, open-label trial in patients with newly diagnosed oligometastatic prostate cancer (PC) starting androgen deprivation therapy (ADT)

STAMPEDE2立体定向消融体部放射治疗(SABR)试验:一项针对新诊断寡转移性前列腺癌(PC)患者(开始接受雄激素剥夺治疗(ADT))的III期、随机、开放标签试验

2024-09-010
PRE